GlassScriptPhysician profile
Sara B Guzick
NPI 1932366226
$1,360.25
in general payments reported to CMS, 2019-2025
24 companies · $518 in 2025
The $518 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $69.22 · 2021: $61.57 · 2022: $34.30 · 2023: $117 · 2024: $350 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $182.50 | 2024-2025 | Zurzuvae |
| Organon LLC | $152.64 | 2021-2025 | Nexplanon |
| Pfizer INC. | $131.75 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $115.91 | 2019-2025 | Gardasil 9, Gardasil |
| Astellas Pharma US INC | $82.33 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $72.66 | 2024-2025 | |
| Amgen INC. | $63.78 | 2019-2020 | |
| Dexcom, INC. | $53.96 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $52.48 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $38.01 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $37.46 | 2019-2024 | Acessa Provu System, Omni Hysteroscope |
| Exeltis, USA INC. | $33.70 | 2022-2025 | Slynd |
| Amag Pharmaceuticals, INC. | $31.61 | 2019 | |
| Becton, Dickinson and Company | $30.23 | 2024 | Arista Ah Flexitip |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $27.67 | 2025 | Injectafer |
| Pacira Pharmaceuticals Incorporated | $19.88 | 2019 | |
| Solventum Corporation | $18.46 | 2025 | Prevena |
| Minerva Surgical, INC | $17.33 | 2024 | |
| Coopersurgical, INC. | $15.90 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.41 | 2025 | |
| Smith+Nephew, INC. | $14.79 | 2025 | Pico |
| Avion Pharmaceuticals | $14.11 | 2019 | |
| Olympus America INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Guzick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.